ACCESSION: MSBNK-SMB_Measured-HSA001P0147026
RECORD_TITLE: Annotated; L-Glutamine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'16_posi_5650': {'bp': 594153.0, 'sum': 2478924.0}, '11_posi_5631': {'bp': 349083.0, 'sum': 2000137.0}, '6_posi_5629': {'bp': 377111.0, 'sum': 2043885.0}, '15_posi_5651': {'bp': 386953.0, 'sum': 2166592.0}, '10_posi_5630': {'bp': 387240.0, 'sum': 1906150.0}, '9_posi_5643': {'bp': 449345.0, 'sum': 2235566.0}, '12_posi_5651': {'bp': 386968.0, 'sum': 2037330.0}, '17_posi_5673': {'bp': 524188.0, 'sum': 2376519.0}, '19_posi_5715': {'bp': 569091.0, 'sum': 2378055.0}, '14_posi_5651': {'bp': 403280.0, 'sum': 2065315.0}, '8_posi_5629': {'bp': 469595.0, 'sum': 2190083.0}, '5_posi_5630': {'bp': 403502.0, 'sum': 2062095.0}, '4_posi_5645': {'bp': 399900.0, 'sum': 1869744.0}, '18_posi_5706': {'bp': 359517.0, 'sum': 1916047.0}}
COMMENT: RETENTION_TIME_STDEV 0.055
COMMENT: PRECURSOR_M/Z_RAW 147.076080
COMMENT: PRECURSOR_M/Z_STDEV 0.000045
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.027; C5H10N2O3; [M+H]+; delta(ppm) 0.027384
COMMENT: PROPOSED_MF MS-FINDER 4.222; C5H10N2O3; [M+H]+; delta(ppm) 0.022902
COMMENT: PROPOSED_MF SIRIUS5_Sirius 28.230; C5H10N2O3; [M+H]+; delta(ppm) 0.022902
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H10N2O3; [M+H]+; delta(ppm) 0.022902
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.743; C5H10N2O3; [M+H]+; delta(ppm) 0.022902
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.181; C3H8N5O2; [M+H]+; delta(ppm) 9.152005
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H10N2O3; [M+H]+; delta(ppm) 0.022902
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 21.000; ZDXPYRJPNDTMRX-VKHMYHEASA-N; C5H10N2O3; GLUTAMINE - 30.0 eV
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 7.000; ZDXPYRJPNDTMRX-UHFFFAOYSA-N; C5H10N2O3; L-GLUTAMINE
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; ZDXPYRJPNDTMRX-GSVOUGTGSA-N; C5H10N2O3; Glutamine 
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.604; ZDXPYRJPNDTMRX-VKHMYHEASA-N; [M+H]+; L-Glutamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.043; PHENTZNALBMCQD-UHFFFAOYNA-N; [M+H]+; Ureidoisobutyric acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.857; CXISPYVYMQWFLE-UHFFFAOYNA-N; [M+H]+; Alanylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.648; VPZXBVLAVMBEQI-VKHMYHEASA-N; [M+H]+; Gly-Ala
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.637; AEFLONBTGZFSGQ-VKHMYHEASA-N; [M+H]+; 4-Amido-4-Carbamoyl-Butyric Acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.520; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M+H]+; N(4)-methyl-L-asparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.518; QYTWIMMLQKHPGL-UHFFFAOYSA-N; [M+H]+; UNPD51326
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.516; XOYSDPUJMJWCBH-GSVOUGTGSA-N; [M+H]+; (3R)-3,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.516; YSPAKPPINKSOKX-SGAVLPGINA-N; [M+H]+; UNPD92492
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.509; XWBUDPXCXXQEOU-UHFFFAOYSA-N; [M+H]+; methyl 2-amino-3-carbamoylpropanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.503; VYAMLSCELQQRAE-UHFFFAOYSA-N; [M+H]+; 2-[(2-aminoacetyl)-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.494; NRUKNRPYMNPMRU-SEFKMRKONA-N; [M+H]+; UNPD159144
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.480; QDILBYVMDFZEFI-UHFFFAOYSA-N; [M+H]+; 3-[(aminomethyl)-C-hydroxycarbonimidoyl]propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.456; QDHYJVJAGQLHBA-UHFFFAOYSA-N; [M+H]+; beta-Ala-Gly
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.430; CJTCFFRJBBMUBJ-UHFFFAOYSA-N; [M+H]+; UNPD71039
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.422; HUESNBGSDPNMHU-VFRCHXTQNA-N; [M+H]+; UNPD83830
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.306; ZMGMDXCADSRNCX-IMJSIDKUSA-N; [M+H]+; (5S,6S)-5,6-dihydroxy-1,3-diazepan-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.940; LGJMYGMNWHYGCB-UHFFFAOYNA-N; [M+H]+; 4,5-dihydroxy-1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CXISPYVYMQWFLE-UHFFFAOYNA-N; [M+H]+; Alanylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZDXPYRJPNDTMRX-VKHMYHEASA-N; [M+H]+; L-Glutamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M+H]+; N(4)-methyl-L-asparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QDHYJVJAGQLHBA-UHFFFAOYSA-N; [M+H]+; beta-Ala-Gly
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VPZXBVLAVMBEQI-VKHMYHEASA-N; [M+H]+; Gly-Ala
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AEFLONBTGZFSGQ-VKHMYHEASA-N; [M+H]+; 4-Amido-4-Carbamoyl-Butyric Acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YSPAKPPINKSOKX-SGAVLPGINA-N; [M+H]+; UNPD92492
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VYAMLSCELQQRAE-UHFFFAOYSA-N; [M+H]+; 2-[(2-aminoacetyl)-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; XOYSDPUJMJWCBH-GSVOUGTGSA-N; [M+H]+; (3R)-3,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QDILBYVMDFZEFI-UHFFFAOYSA-N; [M+H]+; 3-[(aminomethyl)-C-hydroxycarbonimidoyl]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.934; HUESNBGSDPNMHU-VFRCHXTQNA-N; [M+H]+; UNPD83830
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.927; XWBUDPXCXXQEOU-UHFFFAOYSA-N; [M+H]+; methyl 2-amino-3-carbamoylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.792; NRUKNRPYMNPMRU-SEFKMRKONA-N; [M+H]+; UNPD159144
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.758; PHENTZNALBMCQD-UHFFFAOYNA-N; [M+H]+; Ureidoisobutyric acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.758; QYTWIMMLQKHPGL-UHFFFAOYSA-N; [M+H]+; UNPD51326
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.687; ZMGMDXCADSRNCX-IMJSIDKUSA-N; [M+H]+; (5S,6S)-5,6-dihydroxy-1,3-diazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.664; CJTCFFRJBBMUBJ-UHFFFAOYSA-N; [M+H]+; UNPD71039
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.058; LGJMYGMNWHYGCB-UHFFFAOYNA-N; [M+H]+; 4,5-dihydroxy-1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.470; ZDXPYRJPNDTMRX-VKHMYHEASA-N; [M+H]+; (2S)-2,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.263; CXISPYVYMQWFLE-VKHMYHEASA-N; [M+H]+; 2-[[(2S)-2-aminopropanoyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.424; PHENTZNALBMCQD-UHFFFAOYSA-N; [M+H]+; 3-(carbamoylamino)-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.165; AEFLONBTGZFSGQ-VKHMYHEASA-N; [M+H]+; (4S)-4,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.153; VYAMLSCELQQRAE-UHFFFAOYSA-N; [M+H]+; 2-[(2-aminoacetyl)-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; ZXUIRBYHSIZRJC-UHFFFAOYSA-N; [M+H]+; 2-(3-aminooxyazetidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; SBUPBLSDZSZQBG-UHFFFAOYSA-N; [M+H]+; 1,4-dioxane-2-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; VPZXBVLAVMBEQI-UHFFFAOYSA-N; [M+H]+; 2-[(2-aminoacetyl)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M+H]+; (2S)-2-amino-4-(methylamino)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; QDHYJVJAGQLHBA-UHFFFAOYSA-N; [M+H]+; 2-(3-aminopropanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; HCPOCMMGKBZWSJ-UHFFFAOYSA-N; [M+H]+; ethyl 3-hydrazinyl-3-oxopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; XWBUDPXCXXQEOU-UHFFFAOYSA-N; [M+H]+; methyl 2,4-diamino-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; XXNZVJWJWMVONK-UHFFFAOYSA-N; [M+H]+; methyl 2-[(2-aminoacetyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; QYTWIMMLQKHPGL-UHFFFAOYSA-N; [M+H]+; 4-(carbamoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; FMXWPTBQTITILA-UHFFFAOYSA-N; [M+H]+; 2-(carbamoylamino)-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; YZKPZSDKMUSSHE-UHFFFAOYSA-N; [M+H]+; 2-(carbamoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.683; YKPKXMAVLXBQDT-UHFFFAOYSA-N; [M+H]+; ethyl 2-(carbamoylamino)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.561; WJDYAEIVFPVODA-UHFFFAOYSA-N; [M+H]+; ethyl 3-amino-3-hydroxyiminopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.491; WVJOGYWFVNTSAU-UHFFFAOYSA-N; [M+H]+; 1,3-bis(hydroxymethyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.377; RAUQLNDTFONODT-UHFFFAOYSA-N; [M+H]+; ethyl N-ethyl-N-nitrosocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.333; SJLBIPLIGYWGJV-UHFFFAOYSA-N; [M+H]+; 4-[methyl(nitroso)amino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.309; LGJMYGMNWHYGCB-UHFFFAOYSA-N; [M+H]+; 4,5-dihydroxy-1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.208; RUJKVOHTKUJZBV-UHFFFAOYSA-N; [M+H]+; 2-methyl-3-[methyl(nitroso)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; IIGUXNQRQSATOU-UHFFFAOYSA-N; [M+H]+; ethyl 2-[methyl(nitroso)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; MMAVGZKLTAOVSO-UHFFFAOYSA-N; [M+H]+; [ethyl(nitroso)amino]methyl acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -1.666; ZDXPYRJPNDTMRX; [M+H]+; glutamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -99.957; AEFLONBTGZFSGQ; [M+H]+; |A-glutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.242; OPVPFHGQNVWIEH; [M+H]+; N~5~-Hydroxy-L-Ornithine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.030; XOYSDPUJMJWCBH; [M+H]+; 3,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.492; QYTWIMMLQKHPGL; [M+H]+; 4-ureidobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.839; CFRMVEKWKKDNAH; [M+H]+; N(4)-methylasparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.747; JNBAANABXDTZJY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.902; VQVHCAXHYBLRIF; [M+H]+; beta-Methyl-asparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.238; XWBUDPXCXXQEOU; [M+H]+; methyl asparaginate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.242; YSPAKPPINKSOKX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.103; QDHYJVJAGQLHBA; [M+H]+; beta-Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.031; YOKCETMQAPIAGM; [M+H]+; Gly-betaAla
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.071; MXEGHMONPVXZCB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.886; SJLBIPLIGYWGJV; [M+H]+; Nitrosomethyl-3-carboxypropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.985; QDILBYVMDFZEFI; [M+H]+; N-(Aminomethyl)succinamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.007; YKPKXMAVLXBQDT; [M+H]+; Ethyl ureidoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.619; PHENTZNALBMCQD; [M+H]+; beta-Uba
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.888; CXISPYVYMQWFLE; [M+H]+; Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.646; CJTCFFRJBBMUBJ; [M+H]+; propyl N-carbamoylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.689; HCPOCMMGKBZWSJ; [M+H]+; ACMC-20akzl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.511; VDQFWSAIURVIGH; [M+H]+; N2-acetylserinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.366; RAUQLNDTFONODT; [M+H]+; Ethylnitrosourethan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.749; FMXWPTBQTITILA; [M+H]+; N-Carbamyl-|A-aminoisobutyric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.111; VPZXBVLAVMBEQI; [M+H]+; Glcylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.397; NRUKNRPYMNPMRU; [M+H]+; 3-pyridazinecarboxylic acid,hexahydro-5-hydroxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.758; VYAMLSCELQQRAE; [M+H]+; Gly-Sarcosin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.559; WVJOGYWFVNTSAU; [M+H]+; Zeset S
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.323; WJDYAEIVFPVODA; [M+H]+; ethyl 3-amino-3-hydroxyiminopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.628; PSXXKGJXVFZKFB; [M+H]+; methyl-carbamoyl-D-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.487; IIGUXNQRQSATOU; [M+H]+; Sarcosine, ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -317.120; OSABMSLCGCTLLC; [M+H]+; 4,5-dimethoxyimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.721; JVRYDNOVFYKHND; [M+H]+; (3R,4R,5R)-3-(hydroxymethyl)-3,4,5,6-tetrahydropyridazine-4,5-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.852; LGJMYGMNWHYGCB; [M+H]+; 4,3-dimethyl-2-imidazalidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.874; MMAVGZKLTAOVSO; [M+H]+; Acetoxymethylethylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -450.065; HUESNBGSDPNMHU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.922; ZDXPYRJPNDTMRX; [M+H]+; glutamin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -38.368; ZDXPYRJPNDTMRX; [M+H]+; Hgln
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.633; OPVPFHGQNVWIEH; [M+H]+; (2S,5E)-2-amino-5-hydroxyiminopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.596; AEFLONBTGZFSGQ; [M+H]+; 4,5-Diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -289.746; XOYSDPUJMJWCBH; [M+H]+; (3S)-3,5-Diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -304.674; JNBAANABXDTZJY; [M+H]+; (2S)-4-amino-2-(aminomethyl)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -333.206; ZMGMDXCADSRNCX; [M+H]+; 5,6-Dihydroxyhexahydro-2H-1,3-diazepine-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -339.967; QYTWIMMLQKHPGL; [M+H]+; 4-(carbamoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -340.945; VQVHCAXHYBLRIF; [M+H]+; (2S)-2,4-diamino-3-(deuteriomethyl)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -344.012; WVJOGYWFVNTSAU; [M+H]+; 2-Imidazolidinone, 1,3-bis(hydroxymethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -358.424; CJTCFFRJBBMUBJ; [M+H]+; propyl N-carbamoylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.990; ZDXPYRJPNDTMRX; [M+H]+; Hgln
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match L-Glutamine, ZDXPYRJPNDTMRX-VKHMYHEASA-N; Matching to 21 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000641;HMDB0003423;
CH$NAME: L-Glutamine
CH$NAME: (2S)-2,5-diamino-5-oxopentanoic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H10N2O3
CH$EXACT_MASS: 146.069142
CH$SMILES: C(CC(=O)N)[C@@H](C(=O)O)N
CH$IUPAC: InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1
CH$LINK: CHEBI CHEBI:17061
CH$LINK: HMDB HMDB0000641
CH$LINK: INCHIKEY ZDXPYRJPNDTMRX-VKHMYHEASA-N
CH$LINK: PUBCHEM CID:5961
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 11.327
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 147.076422
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-5900000000-2108d67b9a53a7b6cc85
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495526 57.0088 56.050184 0.9634 7.52 0.5692 14 f{C3H6N1}/1.37ppm,p-C2H5N1O3
  70.0650298 26.5174 70.065649 0.8849 6.95 -0.4681 14 f{C4H8N1}/-1.37ppm,p-C1H3N1O3
  73.0759845 42.2217 73.076584 1.1221 9.02 0.4374 14 f{C3H9N2}/-0.55ppm,p-C2H2O3
  84.0443851 698.3137 84.044877 0.3094 67.51 0.8549 14 f{C4H6N1O1}/-0.06ppm,p-C1H5N1O2
  84.0806592 14.4653 84.081151 2.0338 3.89 0.0418 14 f{C5H10N1}/-1.39ppm,p-H1N1O3
  86.0600469 48.0549 86.060514 1.1039 9.89 0.4681 14 f{C4H8N1O1}/0.08ppm,p-C1H3N1O2
  87.0633644 55.3285 87.063818 1.4128 10.71 0.4725 14 ?
  87.0916890 890.2322 87.092142 0.2871 148.50 0.0198 14 f{C4H11N2}/0.16ppm,p-C1O3
  100.0756346 15.8597 100.075956 1.8286 4.92 -0.2396 14 f{C5H10N1O1}/-0.56ppm,p-H1N1O2
  101.0709444 74.7552 101.071257 0.6827 11.85 0.8330 14 f{C4H9N2O1}/0.05ppm,p-C1H2O2
  102.0549451 29.8273 102.055249 1.2346 5.94 0.5429 14 f{C4H8N1O2}/-0.10ppm,p-C1H3N1O1
  104.0705904 46.2151 104.070876 1.4029 5.94 0.5780 14 f{C4H10N1O2}/-0.14ppm,p-C1H1N1O1
  104.1181858 31.9280 104.118471 1.1717 8.03 0.0857 14 ?
  112.0756852 195.2221 112.075890 0.5443 31.59 0.1604 14 ?
  113.1073268 161.0083 113.107520 0.4509 28.28 -0.0374 14 ?
  129.1022158 22.3323 129.102199 1.7041 5.57 -0.0286 14 ?
  129.1219718 37.5812 129.121954 2.3699 7.65 0.2264 14 ?
  130.0499115 999.0000 130.049880 0.3153 93.35 0.8681 14 f{C5H8N1O3}/0.32ppm,p-H3N1
  130.0862891 582.1949 130.086257 0.3382 91.29 0.4813 14 ?
  130.1338907 290.4841 130.133858 0.2613 46.74 0.0154 14 ?
  147.0763424 114.8408 147.076242 0.4963 13.60 1.0000 14 f{C5H11N2O3}/-0.52ppm,p
  147.1127974 168.1658 147.112697 0.6390 34.69 0.1604 14 ?
  147.1603774 449.5002 147.160277 0.3058 70.27 0.2308 14 ?
PK$NUM_PEAK: 23
PK$PEAK: m/z int. rel.int.
  56.049553 57.01 57
  70.065030 26.52 26
  73.075984 42.22 42
  84.044385 698.31 698
  84.080659 14.47 14
  86.060047 48.05 48
  87.063364 55.33 55
  87.091689 890.23 890
  100.075635 15.86 15
  101.070944 74.76 74
  102.054945 29.83 29
  104.070590 46.22 46
  104.118186 31.93 31
  112.075685 195.22 195
  113.107327 161.01 161
  129.102216 22.33 22
  129.121972 37.58 37
  130.049911 999.00 999
  130.086289 582.19 582
  130.133891 290.48 290
  147.076342 114.84 114
  147.112797 168.17 168
  147.160377 449.50 449
//
